HAILEY LANGSTON: Open Payments
NPI 1720744279 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,007 in 33 payments from 10 companies in 2025. Trend: 2023 $293 · 2024 $274 · 2025 $1,007
Food & beverage: $1,007
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 7 | $422 |
| PFIZER INC. | 7 | $156 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $106 |
| Alnylam Pharmaceuticals Inc. | 3 | $101 |
| E.R. Squibb & Sons, L.L.C. | 4 | $83 |
| Merck Sharp & Dohme LLC | 3 | $55 |
| United Therapeutics Corporation | 1 | $30 |
| Novo Nordisk Inc | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Boston Scientific Corporation | 1 | $15 |
Products named: Barostim Neo System, VYNDAQEL, Kerendia, CAMZYOS, ONPATTRO, VERQUVO, Tyvaso, AMVUTTRA.
Industry payments across TX — which companies pay providers there.
